29/11/2019 - Research

Science at the IGTP becomes performance art in the hands of the Fura dels Baus’s Epicalab

Two groups at the IGTP have taken part in the workshop "Complex Systems" organized by the Èpica Foundation. The experience is a first for the IGTP and has meant that art and science have worked together to produce results for both of them. Èpica is a space for interdisciplinary learning and training for the performing arts run by the Fura dels Baus. The results of the workshop are based on research projects from the IGTP and will be shown this Friday and Saturday 29 and 30 November at the Èpica headquarters in Badalona.

27/11/2019 - Research, Success Stories

A study of an atypical form of DM1 will improve the diagnosis and management of this rare disease

The Neuromuscular and Neuropediatric Group at the IGTP, led by Gisela Nogales-Gadea have identified a subset of patients with an atypical type of myotonic dystrophy type 1 (MD1), which develops later and with more severe symptoms than usual. This has important implications for diagnosis of these patients, who can be misdiagnosed or not given the correct prognosis. It is also vital for managing the disease correctly in patients and their families. The study has been published in Human Mutation.

21/11/2019 - Campus Can Ruti, Conferences, Research

Germans Trias Professionals organize the first National Meeting on Neurofibromatosis Type 2

Last Friday the first update meeting at national level to take a global view of the healthcare situation and present the latest research data for Neurofibromatosis type 2 (NF2) took place at the IGTP. This pioneering event was organized by the members of the National Reference Centre in genetic neuro-cutaneous syndromes (Facomatosis), (CSUR) on the Can Ruti Campus and also included patients and families affected by the disease.

14/11/2019 - Research

Talking about diabetes type 1 for World Diabetes Day

To celebrate World Diabetes Day we will literally be talking about the illness at the IGTP; several members of the Immunology of Diabetes Group, which is led by Marta Vives-Pi and concentrates on research into diabetes type 1, will be taking part in talks and discussions in scientific and public forums during the next few days.

13/11/2019 - Research

A new step towards reaching the WHO targets to eliminate HCV infection

Researchers from the Germans Trias i Pujol Hospital and Institute have developed and successfully validated a new one-step screening method to diagnose active hepatitis C virus (HCV) infection in people who inject drugs. The new method  will permit better planning of future more effective actions to improve diagnostics and treatments for this vulnerable group. The study also estimated the prevalence of HCV infection in this community and showed that many people tested do not know that they are infected.

06/11/2019 - Research

Researchers reveal how beta cells in the pancreas respond to an inflammatory environment and how this response is implicated in the risk of developing Type 1 diabetes

The results point to a much more active role for pancreatic beta cells in type 1 diabetes than previously appreciated and suggests a mechanism that may play a key role in other auto-immune diseases.

31/10/2019 - Institutional, Projects, Research

The “La Marató de TV3” Foundation funds three cancer Research projects at Germans Trias

Yesterday evening the ceremony to present awards to the 43 projects that will receive funding for cancer research from the 2018 edition of the La Marató de TV3 and Catalunya Radio was held at the Academy of Medical Sciences. Three of the projects will be carried out under the leadership of Germans Trias professionals.

30/10/2019 - Research

The Hereditary Cancer group expands the use of its gene panel to test for more RASopathies

In 2017 the team designed and tested a gene panel, in collaboration with the ICO, to standardize and simplify genetic testing for hereditary cancer. In the current work the group has validated and extended the use of this panel in the routine genetic testing for  different RASopathies. These are other genetic diseases caused by mutations in genes of the Ras/MAPK pathway for which patients exhibit an overlapping clinical presentation with NF1, especially in children.

29/10/2019 - Research

The importance of COST Action Networks in increasing research collaborations for rare diseases

In the context of research and especially in the case of research into rare diseases, the COST Action Projects (Cooperation in Science and Technology) are key to fostering transnational cooperation. This is the message that a group of Spanish scientists, which includes Dr Gisela Nogales, have sent in a letter recently published in The Lancet Neurology.

16/10/2019 - Research

The world’s largest non-profit funder of type 1 diabetes Research provides half a million dollars for Spanish T1D scientists

The Juvenile Diabetes Research Foundation (JDRF) is supporting a team of scientists that includes a group at the IGTP, led from the Andalusian research centre Cabimer, in their search for a cure for type 1 diabetes (T1D). Researchers in the Immunology of Diabetes Group at the IGTP are participating in the project as expert immunologists as they have wide experience of immunotherapies for T1D.